175 related articles for article (PubMed ID: 14705869)
1. Clinical relevance of P-glycoprotein in drug therapy.
Lin JH; Yamazaki M
Drug Metab Rev; 2003 Nov; 35(4):417-54. PubMed ID: 14705869
[TBL] [Abstract][Full Text] [Related]
2. How significant is the role of P-glycoprotein in drug absorption and brain uptake?
Lin JH
Drugs Today (Barc); 2004 Jan; 40(1):5-22. PubMed ID: 14988766
[TBL] [Abstract][Full Text] [Related]
3. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
4. The role of P-glycoprotein in drug resistance in multiple myeloma.
Abraham J; Salama NN; Azab AK
Leuk Lymphoma; 2015 Jan; 56(1):26-33. PubMed ID: 24678978
[TBL] [Abstract][Full Text] [Related]
5. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
Bansal T; Jaggi M; Khar RK; Talegaonkar S
J Pharm Pharm Sci; 2009; 12(1):46-78. PubMed ID: 19470292
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
Binkhathlan Z; Lavasanifar A
Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
Breier A; Barancík M; Sulová Z; Uhrík B
Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
[TBL] [Abstract][Full Text] [Related]
8. Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier.
Demeule M; Régina A; Jodoin J; Laplante A; Dagenais C; Berthelet F; Moghrabi A; Béliveau R
Vascul Pharmacol; 2002 Jun; 38(6):339-48. PubMed ID: 12529928
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance.
Johnson WW
Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):501-14. PubMed ID: 12500430
[TBL] [Abstract][Full Text] [Related]
10. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological strategies for overcoming multidrug resistance.
Nobili S; Landini I; Giglioni B; Mini E
Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
[TBL] [Abstract][Full Text] [Related]
12. The role of ABC transporters in clinical practice.
Leonard GD; Fojo T; Bates SE
Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494
[TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation.
Shustik C; Dalton W; Gros P
Mol Aspects Med; 1995; 16(1):1-78. PubMed ID: 7783568
[No Abstract] [Full Text] [Related]
14. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins.
Jodoin J; Demeule M; Fenart L; Cecchelli R; Farmer S; Linton KJ; Higgins CF; Béliveau R
J Neurochem; 2003 Nov; 87(4):1010-23. PubMed ID: 14622130
[TBL] [Abstract][Full Text] [Related]
15. Effect of endogenous multidrug resistance 1 and P-glycoprotein expression on anticancer drug resistance in colon cancer cell lines.
Washio I; Nakanishi T; Ishiguro N; Bister B; Tamai I
Biopharm Drug Dispos; 2019 Jan; 40(1):32-43. PubMed ID: 30556139
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
17. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
18. The structure and functions of P-glycoprotein.
Li Y; Yuan H; Yang K; Xu W; Tang W; Li X
Curr Med Chem; 2010; 17(8):786-800. PubMed ID: 20088754
[TBL] [Abstract][Full Text] [Related]
19. Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM; Thomas DG; Darling JL
Anticancer Drugs; 1999 Nov; 10(10):861-72. PubMed ID: 10630353
[TBL] [Abstract][Full Text] [Related]
20. The P-glycoprotein multidrug transporter.
Fardel O; Lecureur V; Guillouzo A
Gen Pharmacol; 1996 Dec; 27(8):1283-91. PubMed ID: 9304397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
